Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.

Auteurs Ben Sahra I, Regazzetti C, Robert G, Laurent K, Le Marchand-Brustel Y, Auberger P, Tanti JF, Giorgetti-Peraldi S, Bost F

Cancer research Mai 2011

Inhibition of hedgehog signaling decreases proliferation and clonogenicity of human mesenchymal stem cells.

Auteurs Plaisant M, Giorgetti-Peraldi S, Gabrielson M, Loubat A, Dani C, Peraldi P

PloS one Feb 2011

Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity.

Auteurs Jager J, Corcelle V, Grémeaux T, Laurent K, Waget A, Pagès G, Binétruy B, Le Marchand-Brustel Y, Burcelin R, Bost F, Tanti JF

Diabetologia Jan 2011

The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells.

Auteurs Ben Sahra I, Tanti JF, Bost F

Autophagy Jul 2010

The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells.

Auteurs Ben Sahra I, Tanti JF, Bost F

Autophagy Jul 2010

Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.

Auteurs Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, Attané C, Wanecq E, Guigné C, Bost F, Tanti JF, Laville M, Vidal H, Valet P, Castan-Laurell I

American journal of physiology. Endocrinology and metabolism Jun 2010

Metformin in cancer therapy: a new perspective for an old antidiabetic drug?

Auteurs Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F

Molecular cancer therapeutics May 2010

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.

Auteurs Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, Le Marchand-Brustel Y, Giorgetti-Peraldi S, Cormont M, Bertolotto C, Deckert M, Auberger P, Tanti JF, Bost F

Cancer research Mar 2010

Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes.

Auteurs Regazzetti C, Bost F, Le Marchand-Brustel Y, Tanti JF, Giorgetti-Peraldi S

The Journal of biological chemistry Déc 2009

Hypoxia decreases insulin signaling pathways in adipocytes.

Auteurs Regazzetti C, Peraldi P, Grémeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, Bost F, Le Marchand-Brustel Y, Tanti JF, Giorgetti-Peraldi S

Diabetes Nov 2008